Results 61 to 70 of about 25,057 (208)

Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus

Научно-практическая ревматология, 2020
Neuropsychiatric disorders in juvenile-onset systemic lupus erythematosus (SLE) stay in the focus of attention in recent decades due to significant influence of CNS lesions on SLE course in general, necessity to optimize therapeutic interventions and ...
M. I. Kaleda, I. P. Nikishina
doaj   +1 more source

Autoimmune gastrointestinal complications in patients with Systemic Lupus Erythematosus: case series and literature review [PDF]

, 2016
The association of systemic lupus erythematosus (SLE) with gastrointestinal autoimmune diseases is rare, but has been described in the literature, mostly as case reports.
Agmon-Levin N, Ahmed QM, Akram S, Arnett FC, Bessone F, Breuer GS, Byun JY, Cabrera GE, Carmona-Fernandes D, Carone FA, Chebli JM, Chong WP, Chowdhary VR, Cortese AF, Cowling DC, Criş cov GI, Culp KS, D A Isenberg, De Jager PL, Denham JM, Dreiling DA, Dubois EL, Ebert EC, Efe C, Efe C, Einarsdottir E, Essaadouni L, Fernández Rodríguez AM, Ferreiros-Vidal I, Fina D, Floreani A, Freeman HJ, Gershwin ME, Gibson T, Grimbacher B, Gupta D, Hallegua DS, Hamed I, Han S, Harada K, Hennes EM, Her M, Homberg JC, Irving KS, Isenberg DA, Janssens P, Joske RA, Ju JH, Kapila N, Katsanos KH, Katsanos KH, Laing TJ, Lee C-K, Leggett BA, Leonard WJ, Levy C, Lohse AW, Ludvigsson JF, Mackay IR, Makol A, Matsumoto T, Medina F, Michalopoulos G, Miller MH, Miyazaki T, Muratori P, Nakou M, Nesher G, Netto AP, Nitzan O, Park SW, Pascual-Ramos V, Pisetsky DS, Pollak VE, Reifenstein EC, Rensch MJ, Reynolds JC, Rodriguez EA, Runyon BA, Rustgi AK, S Custódio Alves, S Fasano, Seelig R, Serrano López MC, Shapeero LG, Shizuma T, Shizuma T, Sparberg M, Steffan W, Sultan SM, Sánchez-Guerrero J, Takahashi A, Taourel P, Thomas JR, Tian X-P, van Hoek B, Vergani D, Vitali C, Yamashita H, Zheng R-H, Zizic TM, Zizic TM   +101 more
core   +1 more source

Autoantibody Response Toward Chromatin in Patients With Juvenile Idiopathic Arthritis

Arthritis &Rheumatology, EarlyView.
Objective Patients with juvenile idiopathic arthritis (JIA) frequently exhibit antinuclear antibodies (ANAs), but the specific antigen target recognized by them and the presence of additional autoantibody specificities in patients with JIA remains elusive.
Viola Pitkänen, Terhi Remes‐Pakarinen, Paula Vähäsalo, Milja Möttönen, Minna‐Maija Grönlund, Miika Arvonen, Mikael Knip, Riitta Veijola, Jorma Toppari, Jorma Ilonen, Johanna Lempainen, Anna‐Mari Schroderus, Liisa Kröger, Tuure Kinnunen   +13 more
wiley   +1 more source

The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus [PDF]

, 2014
BACKGROUND: The involvement of high mobility group box-1 (HMGB1) in various inflammatory and autoimmune diseases has been documented but clinical trials on the contribution of this pro-inflammatory alarmin in children with juvenile idiopathic ...
Bobek, Dubravka, Grčević, Danka, Jelušić, Marija, Kovačić, Nataša, Lukić, Ivan Krešimir   +4 more
core   +1 more source

Rituximab therapy for juvenile-onset systemic lupus erythematosus [PDF]

Pediatric Nephrology, 2007
Rituximab (RTX), an anti-CD20 monoclonal antibody, has been proposed for use in the therapy of systemic lupus erythematosus (SLE). We present the initial long-term experience of the safety and efficacy of rituximab for treatment of SLE in children.
Nwobi, Obioma, Abitbol, Carolyn L., Chandar, Jayanthi, Seeherunvong, Wacharee, Zilleruelo, Gastón   +4 more
openaire   +2 more sources

P048 Juvenile systemic lupus erythematosus, what specificities?

Rheumatology, 2021
Abstract Background Juvenile systemic lupus erythematosus (J-SLE) is a chronic autoimmune disease characterized by multi-visceral involvement with an unpredictable prognosis. The diagnosis is usually made in young women between the ages of 20 and 40, however, it can set in at any age and will be ...
Kamelia Okka, M Belghazi, A Dehimi, Z Benarab, S Bouabdallah, B Bioud   +5 more
openaire   +1 more source

Serum Cytokine Profiling Differentiates Underlying Diseases in Cytokine Storm Syndrome

Arthritis &Rheumatology, EarlyView.
Serum cytokine profiling was performed using Luminex (48 cytokines) and ELISA (5 cytokines). Assessment of key cytokines (IFN‐α, IL‐18, IL‐6, CXCL9) delineated five dominant inflammatory patterns: I, IFN‐α–dominant CSS; II, IL‐18–dominant CSS; III, IL‐6–dominant CSS; IV, IFN‐γ–dominant CSS; and V, IL‐6 & IFN‐γ intermediate CSS.
Shuya Kaneko, Maho Hatano, Asami Shimbo, Futaba Miyaoka, Hitoshi Irabu, Yuko Akutsu, Yuko Hayashi, Mao Mizuta, Yasuo Nakagishi, Keiji Akamine, Naomi Iwata, Kenji Furuno, Takayuki Tanaka, Kazuyuki Ueno, Shuhei Fujita, Koji Yokoyama, Toshinori Minato, Kazushi Izawa, Takahiro Yasumi, Tadashi Matsubayashi, Tadashi Hosoya, Hiroki Nishikawa, Junya Fujimura, Ryoko Asano, Yuko Sugita, Kenichi Watanabe, Anna Kobayashi, Takuya Endo, Katsuhide Eguchi, Ryuta Nishikomori, Ryuhei Yasuoka, Takaki Asano, Miyako Kanno, Kazuya Hamada, Yuji Fujita, Daisuke Hayashi, Shojiro Watanabe, Takeshi Shiba, Shinsuke Yasuda, Masaaki Mori, Hirokazu Kanegane, Masatoshi Takagi, Masaki Shimizu   +42 more
wiley   +1 more source

International validation of a urinary biomarker panel for identification of active lupus nephritis in children. [PDF]

, 2016
Conventional markers of juvenile-onset systemic lupus erythematosus (JSLE) disease activity fail to adequately identify lupus nephritis (LN). While individual novel urine biomarkers are good at detecting LN flares, biomarker panels may improve diagnostic
Beresford, MW, Corkhill, R, Ekdawy, D, Goilav, B, Jones, CA, Jorgensen, AL, Marks, SD, Midgley, A, Newland, P, Oni, L, Pilkington, C, Putterman, C, Rubinstein, T, Smith, EMD, Tullus, K, Wahezi, D   +15 more
core   +2 more sources

Juvenile Systemic Lupus Erythematosus in 60 Saudi Children

Annals of Saudi Medicine, 1997
A ten-year retrospective analysis of the clinical features and survival of 60 Saudi children with systemic lupus erythematosus (SLE) was made. All the patients fulfilled the 1982 American College of Rheumatologyâs revised criteria for SLE and had had the disease at or before the age of 16 years.
S, Bahabri, E A, Sabban, A, Al Rashed, S, Al-Mayouf, A, Al Mazyed, A, Abdulrazik, A, Al-Dalaan   +6 more
openaire   +2 more sources

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source